95k base salary with a tiered commission structure. If you hit your number, 100k sales/month, then you’ll make 215k all in.
And no one is concerned about the fact the whole company is under investigation?
No Shorty, we are not. The only people who are concerned are the idiots that did not cover their short under $2 (like you). The company is printing cash, trading at 1x Sales and will be relisted on Nasdaq with a price significantly above it current level before the end of this year.And no one is concerned about the fact the whole company is under investigation?
No Shorty, we are not. The only people who are concerned are the idiots that did not cover their short under $2 (like you). The company is printing cash, trading at 1x Sales and will be relisted on Nasdaq with a price significantly above it current level before the end of this year.
No Shorty, we are not. The only people who are concerned are the idiots that did not cover their short under $2 (like you). The company is printing cash, trading at 1x Sales and will be relisted on Nasdaq with a price significantly above it current level before the end of this year.
The AEs will never beat the tenured relationships from Organogenesis. Health systems are moving to using the exclusively and blocking out the MANY allograft companies seeking to have their products in that space.